Disease area and portfolio strategies
We develop options for clinical development and commercialisation within different disease areas and across product portfolios including:
Prioritisation based on market attractiveness, competitive position and capabilities.
Transparent criteria and evaluation assumptions to define priorities.
Options generation.
Trade-off of revenue opportunity vs. development and commercial potential to define and prioritise disease or market opportunities.
Process improvement
We analyse existing processes, identifying and adapting to opportunities to meet new organisational goals.
We provide:
Alignment of research, development and commercial opportunities to deliver coherent strategy.
Clearly defined decision-making recommendations to improve process flow.
Benchmarking of competitors to help define 'best practice'.
Plans are nothing. Planning is everything."
Dwight D. Eisenhower



  Disease area and portfolio strategies.
  Process improvement.
Strategic initiatives
Copyright  © Fletcher Associates GmbH ¦ All rights reserved
Juliana Soliman, Webdesigner
Chele Mueller, Photography